Platelet responses to compound interactions with thrombin.

Area of Science:

• Biochemistry
• Hematology
• Platelet Biology

Background:

• Thrombin plays a critical role in hemostasis and thrombosis.
• Platelet activation by thrombin involves complex signaling pathways.
• Understanding thrombin-platelet interactions is crucial for developing antithrombotic therapies.

Purpose of the Study:

• To investigate the catalytic and noncatalytic interactions of thrombin variants with platelets.
• To elucidate the roles of specific thrombin receptors and ligands in platelet activation.
• To differentiate the signaling mechanisms of different thrombin forms.

Main Methods:

• Utilized thrombin variants with altered specificities.
• Employed ligands of thrombin receptors on platelets.
• Assessed platelet dense body (ATP) secretion and cytosolic Ca(II) rise.
• Used antibodies to block receptor cleavage and thrombin-glycoprotein Ib binding.

Main Results:

• Alpha-thrombin and meizothrombin-des-fragment-1 (mu-thrombin) efficiently cleave protease-activated receptor 1 (PAR1), while beta-thrombin does not.
• All three thrombin forms stimulate Ca(II) rise, but alpha-thrombin exhibits a unique, highly sensitive Ca(II) response.
• Noncatalytic binding to glycoprotein Ib and PAR1 cleavage both modulate thrombin-induced platelet secretion.
• Alpha-thrombin possesses an activity distinct from mu-thrombin and beta-thrombin, possibly involving a third interaction site or coordinated dual receptor cleavage.

Conclusions:

• Platelet activation by thrombin is mediated by both catalytic cleavage of PAR1 and noncatalytic interactions.
• Alpha-thrombin exhibits unique signaling properties not shared by mu-thrombin or beta-thrombin.
• Glycoprotein Ib occupancy contributes to the modulation of thrombin-induced platelet responses, independent of cytosolic Ca(II).